FEED the BULL

Welcome to Feed the Bull - A home for investment information and interaction.

Tag: TearLab

Sort
E.g., 2013-05-25
E.g., 2013-05-25
Enter a comma separated list of user names.

BLRX, BioLineRx Ltd.

** BLRX reported that it has signed a worldwide, exclusive license agreement with Genoscience, a French company focused on viral disease therapeutics, to develop and commercialize BL-8020, an orally available treatment for Hepatitis C.

Siga Resources Inc (SGAE)

Siga Resources Inc, founded in 2007, is based in South Lake Tahoe, California. Siga is a mineral resource exploration and development company. Siga's strategy targets properties that have the potential for near term production and early positive cash flow. Siga's general geographical interest is North and South America.

TearLab Corporation (Nasdaq:TEAR) announced that it has closed its previously announced private placement of approximately 3.85 million units at a price of $1.82 per unit. Each unit consisted of one share of common stock and a warrant to purchase one share of common stock at an exercise price of US$1.86 per share. The Company has received total gross proceeds of approximately US$7 million.

FREE Daily Stock Alerts From Stock-PR.com

Shares of PVH increased $4.29 (+7.13%), up to $64.46 in early today trading!

Phillips-Van Heusen Corporation has Reported 2010 Fourth Quarter and Full Year Results!

Phillips-Van Heusen Corporation (NYSE:PVH) reported 2010 fourth quarter and full year results.

Fourth Quarter of 2010 Results:

Cleantech Transit Inc. (CLNO)

With the recent and continued increase in wind power, the challenge is clear: how can the energy industry integrate this intermittent power source into the electricity grid?

Stock-PR Reporting

FREE Daily Stock Alerts From Stock-PR.com
________________________________________

Proteonomix, Inc. (OTC.BB:PROT) reported today that Proteonomix has filed a utility patent application for the Preparation and Use of Stromal Cells for Treatment of Cardiac Diseases.

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

ADVERTISE WITH US